Infectious Diseases & Immunity,
Journal Year:
2024,
Volume and Issue:
4(3), P. 132 - 137
Published: June 12, 2024
Abstract
Infection
and
vaccination
can
provide
protective
immunity
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
However,
the
emergence
of
SARS-CoV-2
variants
has
persisted,
leading
to
breakthrough
infections.
Owing
original
antigenic
sin
(OAS),
variant
infection
or
potentially
induces
a
stronger
antibody
response
ancestral
strain
than
subsequent
variants,
as
in
case
influenza.
Thus,
overcoming
OAS
is
important
for
development
future
vaccine
designs.
This
review
summarizes
recent
findings
on
its
with
an
emphasis
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(8), P. 114520 - 114520
Published: July 17, 2024
Highlights•SLip,
FLiRT,
and
KP.2
are
poorly
neutralized
by
bivalent-vaccinated
sera•XBB.1.5-vaccinated
hamster
JN.1
patient
sera
SLip,
KP.2•S
mutations
R346T,
L455S,
F456L
alter
ACE2
binding
neutralization
epitopes•SLip,
spikes
exhibit
less
fusion
processing
relative
to
JN.1SummaryWe
investigate
JN.1-derived
subvariants
for
antibodies
in
vaccinated
individuals,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)-infected
patients,
or
class
III
monoclonal
antibody
S309.
Compared
JN.1,
KP.2,
especially
FLiRT
increased
resistance
BA.2.86/JN.1-wave
convalescent
human
sera.
XBB.1.5
monovalent-vaccinated
robustly
neutralize
but
have
reduced
efficiency
SLip.
All
resistant
S309
show
decreased
infectivity,
cell-cell
fusion,
spike
JN.1.
Modeling
reveals
that
L455S
SLip
reduce
ACE2,
while
R346T
strengthens
it.
These
three
mutations,
alongside
D339H,
key
epitopes
spike,
likely
explaining
the
sensitivity
of
these
neutralization.
Our
findings
highlight
suggest
future
vaccine
formulations
should
consider
as
an
immunogen,
although
current
monovalent
could
still
offer
adequate
protection.Graphical
abstract
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 21, 2024
SARS-CoV-2
variants
derived
from
the
immune
evasive
JN.1
are
on
rise
worldwide.
Here,
we
investigated
JN.1-derived
subvariants
SLip,
FLiRT,
and
KP.2
for
their
ability
to
be
neutralized
by
antibodies
in
bivalent-vaccinated
human
sera,
XBB.1.5
monovalent-vaccinated
hamster
sera
people
infected
during
BA.2.86/JN.1
wave,
class
III
monoclonal
antibody
(Mab)
S309.
We
found
that
compared
parental
JN.1,
SLip
KP.2,
especially
exhibit
increased
resistance
COVID-19
BA.2.86/JN.1-wave
convalescent
sera.
Interestingly,
monovalent
vaccinated
robustly
FLiRT
but
had
reduced
efficiency
SLip.
These
were
resistant
neutralization
Mab
In
addition,
aspects
of
spike
protein
biology
including
infectivity,
cell-cell
fusion
processing,
these
subvariants,
a
decreased
infectivity
membrane
relative
correlating
with
processing.
Homology
modeling
revealed
L455S
F456L
mutations
local
hydrophobicity
hence
its
binding
ACE2.
contrast,
additional
R346T
mutation
strengthened
conformational
support
receptor-binding
motif,
thus
counteracting
effects
F456L.
three
mutations,
alongside
D339H,
which
is
present
all
sublineages,
alter
epitopes
targeted
therapeutic
Mabs,
I
S309,
explaining
sensitivity
Together,
our
findings
provide
insight
into
newly
emerged
suggest
future
vaccine
formulations
should
consider
as
immunogen,
although
current
could
still
offer
adequate
protection.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 5, 2024
SUMMARY
During
the
summer
of
2024,
COVID-19
cases
surged
globally,
driven
by
variants
derived
from
JN.1
subvariants
SARS-CoV-2
that
feature
new
mutations,
particularly
in
N-terminal
domain
(NTD)
spike
protein.
In
this
study,
we
report
on
neutralizing
antibody
(nAb)
escape,
infectivity,
fusion,
and
stability
these
subvariants—LB.1,
KP.2.3,
KP.3,
KP.3.1.1.
Our
findings
demonstrate
all
are
highly
evasive
nAbs
elicited
bivalent
mRNA
vaccine,
XBB.1.5
monovalent
mumps
virus-based
or
infections
during
BA.2.86/JN.1
wave.
This
reduction
nAb
titers
is
primarily
a
single
serine
deletion
(DelS31)
NTD
spike,
leading
to
distinct
antigenic
profile
compared
parental
other
variants.
We
also
found
DelS31
mutation
decreases
pseudovirus
infectivity
CaLu-3
cells,
which
correlates
with
impaired
cell-cell
fusion.
Additionally,
protein
appears
more
conformationally
stable,
as
indicated
reduced
S1
shedding
both
without
stimulation
soluble
ACE2,
increased
resistance
elevated
temperatures.
Molecular
modeling
suggests
induces
conformational
change
stabilizes
strengthens
NTD-Receptor-Binding
Domain
(RBD)
interaction,
thus
favoring
down
conformation
RBD
reducing
accessibility
ACE2
receptor
certain
nAbs.
introduces
an
N-linked
glycan
modification
at
N30,
shields
underlying
region
recognition.
data
highlight
critical
role
mutations
for
evasion,
stability,
viral
suggest
consideration
updating
vaccines
antigens
containing
DelS31.
mBio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
ABSTRACT
During
the
summer
of
2024,
coronavirus
disease
2019
(COVID-19)
cases
surged
globally,
driven
by
variants
derived
from
JN.1
subvariants
severe
acute
respiratory
syndrome
2
that
feature
new
mutations,
particularly
in
N-terminal
domain
(NTD)
spike
protein.
In
this
study,
we
report
on
neutralizing
antibody
(nAb)
escape,
infectivity,
fusion,
and
stability
these
subvariants—LB.1,
KP.2.3,
KP.3,
KP.3.1.1.
Our
findings
demonstrate
all
are
highly
evasive
nAbs
elicited
bivalent
mRNA
vaccine,
XBB.1.5
monovalent
mumps
virus-based
or
infections
during
BA.2.86/JN.1
wave.
This
reduction
nAb
titers
is
primarily
a
single
serine
deletion
(DelS31)
NTD
spike,
leading
to
distinct
antigenic
profile
compared
parental
other
variants.
We
also
found
DelS31
mutation
decreases
pseudovirus
infectivity
CaLu-3
cells,
which
correlates
with
impaired
cell-cell
fusion.
Additionally,
protein
appears
more
conformationally
stable,
as
indicated
reduced
S1
shedding
both
without
stimulation
soluble
ACE2
increased
resistance
elevated
temperatures.
Molecular
modeling
suggests
enhances
NTD-receptor-binding
(RBD)
interaction,
favoring
RBD
down
conformation
reducing
accessibility
specific
nAbs.
Moreover,
introduces
an
N-linked
glycan
at
N30,
shielding
recognition.
These
underscore
role
mutations
immune
evasion,
stability,
viral
highlighting
need
consider
DelS31-containing
antigens
updated
COVID-19
vaccines.
IMPORTANCE
The
emergence
novel
continues
pose
challenges
for
global
public
health,
context
evasion
stability.
study
identifies
key
mutation,
DelS31,
JN.1-derived
escape
while
stabilizes
conformation,
limits
shedding,
increases
thermal
resistance,
possibly
contribute
prolonged
persistence.
Structural
analyses
reveal
interactions
introducing
shielding,
thus
decreasing
accessibility.
emphasize
critical
shaping
evolution
underscoring
urgent
vaccines
account
adaptive
changes.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 16, 2024
Newly
emerged
SARS-CoV-2
variants
like
JN.1,
and
more
recently,
the
hypermutated
BA.2.87.1,
have
raised
global
concern.
We
recruited
two
groups
of
participants
who
had
BA.5/BF.7
breakthrough
infection
post
three
doses
inactivated
vaccines:
one
group
experienced
subsequent
XBB
reinfection,
while
other
received
XBB-containing
trivalent
WSK-V102C
vaccine.
Our
comparative
analysis
their
serum
neutralization
activities
revealed
that
vaccine
induced
stronger
antibody
responses
against
a
wide
range
variants,
notably
including
JN.1
highly
escaped
BA.2.87.1.
Furthermore,
our
investigation
into
specific
mutations
fragment
deletions
in
NTD
significantly
contribute
to
immune
evasion
BA.2.87.1
variant.
findings
emphasize
necessity
for
ongoing
development
adaptation
address
dynamic
nature
variants.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4281 - 4281
Published: April 12, 2024
In
this
study,
we
performed
a
computational
study
of
binding
mechanisms
for
the
SARS-CoV-2
spike
Omicron
XBB
lineages
with
host
cell
receptor
ACE2
and
panel
diverse
class
one
antibodies.
The
central
objective
investigation
was
to
examine
molecular
factors
underlying
epistatic
couplings
among
convergent
evolution
hotspots
that
enable
optimal
balancing
antibody
evasion
variants
BA.1,
BA2,
BA.3,
BA.4/BA.5,
BQ.1.1,
XBB.1,
XBB.1.5,
XBB.1.5
+
L455F/F456L.
By
combining
evolutionary
analysis,
dynamics
simulations,
ensemble-based
mutational
scanning
protein
residues
in
complexes
ACE2,
identified
structural
stability
affinity
are
consistent
results
biochemical
studies.
agreement
deep
experiments,
our
quantitative
analysis
correctly
reproduced
strong
variant-specific
effects
BA.2
variants.
It
shown
Y453W
F456L
mutations
can
enhance
when
coupled
Q493
while
these
become
destabilized
R493
position
variant.
provided
rationale
mechanism
variants,
showing
role
Q493/R493
hotspot
modulating
between
sites
L455F
lineages.
receptors
antibodies
provide
experimental
evidence
interactions
physically
proximal
Y501,
R498,
Q493,
L455F,
determine
binding,
F486P
instrumental
mediating
broad
resistance.
supports
which
impact
on
is
mediated
through
small
group
universal
hotspots,
effect
immune
could
be
more
variant-dependent
modulated
by
conformationally
adaptable
regions.